Global Biotechnology Market

Global Biotechnology Market Size, Share, Growth Analysis, By Technology(Nano-biotechnology, Tissue Engineering), By Application(Health, Food & Agriculture) - Industry Forecast 2023-2030


Report ID: SQSG35H2012 | Region: Global | Published Date: February, 2024 | Pages: 260 | Tables: 71 | Figures: 75

Global Biotechnology Market Insights

Biotechnology Market size was valued at USD 1055.7 billion in 2021 and is poised to grow from USD 1202.44 billion in 2022 to USD 3879.51 billion by 2030, growing at a CAGR of 13.9% in the forecast period (2023-2030).

Biotechnology is an interdisciplinary, cutting-edge field that uses living things, biological systems or their derivatives to alter or develop production processes and therapeutics. It has a significant impact on a variety of industries, including medicine and pharmaceuticals, genomics, food and chemical production, and others. It plays a significant and comprehensive role in addressing pressing issues pertaining to environmental protection, food and energy security, and health and wellbeing. The regulatory support given by governments of different nations, rising food demand, technological advancements to fight severe diseases, and the depletion of natural resources are the main factors driving the biotechnology market. However, the biotechnology industry's expansion is being constrained by a number of problems, including the protracted time it takes for research to be commercialized and public attitudes regarding biotech products. Some of the quickly developing biotechnology technologies of today include nanotechnology, cloning, and stem cell science.

The market is being driven by beneficial government initiatives as a result of the growth of the biotechnology sector in developing nations like China, Japan, and India. The government authority's efforts are aimed at streamlining the clinical research process, enhancing repayment plans, assisting the item endorsement process, and easing the administrative pathway for drugs. All of these initiatives will give the company a solid foundation for future growth. One of the main market barriers for biopharmaceutical medications is the protracted lab-to-market phase. A medicine must be developed for 12 to 15 years before it can be sold on the open market. Clinical trial-related social and ethical problems also serve as a barrier to the growth of the biotechnology business.

US Biotechnology Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 1055.7 billion

Largest Segment

Health

Fastest Growth

Food & Agriculture

Growth Rate

13.9% CAGR

Global Biotechnology Market, 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
Global Biotechnology Market By Application , 2021-2028($ Bn)
Global Biotechnology Market Size By Application , 2021-2028 (%)

To get more reports on the above market click here to Buy The Report

Global Biotechnology Market Segmental Analysis

Global biotechnology market is segmented based on the Technology type, end use and region. Based on Technology the Global biotechnology market is segmented into Nano-biotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, and Chromatography. Based on Application, the market is segmented into Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, and Others.  Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Biotechnology Market Analysis by Technology

Based on Technology, the global biotechnology market is segmented into Nano-biotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, and Chromatography. The segment of DNA sequencing held the larger market share. Due to falling sequencing prices and the increasing adoption of advanced DNA sequencing techniques, DNA sequencing technology dominated the market in 2021 and generated the biggest revenue share. Applications of sequencing to understand diseases have increased thanks to government support for genetic research. For instance, the University of Pittsburgh Graduate School of Public Health and Washington University School of Medicine in St. Louis received a USD 10.7 million NIH grant in May 2021 for the study of the genetic basis of Alzheimer's disease. Applications of theranostics nanoparticles, for instance, have gained momentum in order to facilitate quick diagnosis and customization of therapy options for several illnesses at once. Nanoparticle characteristics including low toxicity, smaller size, and chemical adaptability have proven to be useful in addressing the drawbacks of traditional ways of generic drug delivery. Due to public and private expenditures, high healthcare spending, and the existence of multiple established and up-and-coming firms, tissue engineering and regenerative medicine also retained a sizeable stake.

Biotechnology Market Analysis by Application

Based on Application, the market is segmented into Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, and Others. Among these, the health segment held the larger share. The segment is projected to expand as a result of the rising illness burden, increased availability of agri-biotech products and services, and technological advancements in the bio-industrial sector. Significant developments in the fields of artificial intelligence (AI), machine learning, and big data are also contributing to the segment's growth. These developments are anticipated to increase the penetration of bioinformatics applications, particularly in sectors like the food and beverage industry. The segment of bioinformatics held the second largest market share. The rise in platform application is linked to the life science company's increased demand for structural identification and modification. This would therefore assist in the process of creating new drugs and assessing their therapeutic benefits. Additionally, improved drug development techniques are required due to increased efficiency and safety in drug research and development.

Global Biotechnology Market By Application, 2021(%), 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Biotechnology Market Regional Insights

Global biotechnology market is dominated by North America. The presence of major players, extensive R&D efforts, and high healthcare spending are just a few of the factors driving the regional market's expansion. Platforms based on genomics, proteomics, and cell biology are widely used in the area, which is hastening the uptake of life sciences tools. A further factor that is anticipated to have a positive effect on market growth in the area is the rise in the prevalence of chronic diseases and the increasing use of personalized medicine applications for the treatment of serious illnesses.

Asia Pacific region is fastest growing region till forecasted period. The expansion plans of major market players, favorable government initiatives, and increasing investments in healthcare infrastructure can all be linked to the growth of the regional market. For instance, Moderna Inc. announced in February 2022 that it intended to geographically expand its commercial network in Asia by establishing four new subsidiaries in Malaysia, Singapore, Hong Kong, and Taiwan. Additionally, partnerships in the biopharmaceutical industry, such as the strategic partnership between Kiniksa Pharmaceuticals and Huadong Medicine for the development and commercialization of Kiniksa's ARCALYST and mavrilimumab in the Asia-Pacific region, are anticipated to fuel market expansion.

Global Biotechnology Market By Geography, 2021 - 2028, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Biotechnology Market Dynamics

Biotechnology Market Driver

  • Increasing prevalence of chronic illnesses is believed Chronic conditions are now more common than ever. With the growth of the middle class and the speeding up of urbanization, people are becoming more sedentary. As a result, there are more cases of genetic abnormalities, diabetes, malaria, HIV, and other diseases like TB and obesity. Additional factors driving market revenue growth include an increase in the prevalence of target diseases and genetic anomalies, ongoing technological advancements in Polymerase Chain Reaction technologies, and increased investments, financing, and grants for scientific research. The biopharmaceutical sector aids in the prevention of chronic diseases. Biopharmaceutical sector is focusing on creating individualized therapies. This will help develop individualized procedural healthcare standards and aid in the treatment of some hereditary genetic diseases.
  • The pharmaceutical industry's growing need for enzymes to synthesize intermediates for the production of active pharmaceutical ingredients (API) for potent medicines is predicted to fuel the market's expansion. The ability of an enzyme to transform complex molecules into simpler molecules (starch to glucose) in the food and beverage industry, removal of fats and oil stains in the detergent industry, the production of bioethanol for use in biofuels, and improved bleaching properties in the paper and pulp industries are the factors anticipated to drive the demand for enzymes in the upcoming years.

Biotechnology Market Restraint

  • Clinical trials are at serious risk from the effects of medical biotechnology. Because the technology is so new, testing has resulted in injuries and sometimes fatalities. Before employing technology on human beings, great thought should be given to these risks, and anyone taking part in a trial should be extremely informed of all possible consequences. Unfortunately, there is a paradox whereby sick people will occasionally try new things in the hopes of getting better. This suggests that scientists and medical personnel have a significant ethical obligation to properly disclose the dangers to patients and respect their ultimate decision.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Biotechnology Market Competitive Landscape

Global biotechnology market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Biotechnology Market Top Player's Company Profiles

  • AstraZeneca
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb 
  • Amgen Inc.
  • Biogen Inc.
  • Celgene Corporation (now part of Bristol Myers Squibb)
  • Illumina, Inc.
  • Novo Nordisk A/S
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Roche Holding AG
  • Genentech, Inc. (a subsidiary of Roche Holding AG)
  • Moderna, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Lonza Group AG
  • Pfizer Inc.

Biotechnology Market Recent Developments

  • In Aug 2022, Gilead Sciences, Inc. have entered into a definitive agreement and will acquire MiroBio. The acquisition will provide Gilead with MiroBio’s proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists. MiroBio’s lead investigational antibody, MB272, is a selective agonist of immune inhibitory receptor B- and T-Lymphocyte Attenuator (BTLA) and has entered Phase 1 clinical trials, with the first patient dosed earlier this week. MB272 targets T, B and dendritic cells to inhibit or blunt activation and suppress an inflammatory immune response.
  • In March 2022, Pfizer Inc. the completed of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

Global Biotechnology Key Market Trends

  • By merging cutting-edge technology, expanding developments in the life sciences are providing significant advantages for healthcare interventions and productivity. Innovative technique development and company adoption have a beneficial impact on the biotech industry and are expected to drive significant market growth. Medicine is utilizing cutting-edge technologies, such as 3D bioprinting. Heart valves, cartilage, and skin are just a few of the bodily parts that may be developed using 3D bioprinting and living cells. The development of medications, tissues, and organs like the liver and heart utilizing patient body cells has a tremendous potential. The spectrum of uses for human cells and tissues in medical research will be further expanded because accurate models for research and analysis will be made available.
  • Biosensors are another cutting-edge technology utilized for tracking individual health that has been incorporated thanks to developments in medical technology. Numerous biosignatures like the heartbeat, blood pressure, body temperature, and others are monitored using biosensors. This technology makes it easier to monitor patients remotely and helps medical professionals by giving them important health information.

Global Biotechnology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our Global Biotechnology Market Analysis, in terms of Technology, the segment of DNA sequencing held the larger market share. Due to falling sequencing prices and the increasing adoption of advanced DNA sequencing techniques. In terms of application, the health segment held the larger share. The segment is projected to expand as a result of the rising illness burden, increased availability of Agri-biotech products and services, and technological advancements in the bio-industrial sector.

Report Metric Details
Market size value in 2021 USD 1055.7 billion
Market size value in 2030 USD 3879.51 billion
Growth Rate 13.9%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Technology
    • Nano-biotechnology, Tissue Engineering, Regeneration, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography
  • Application
    • Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • AstraZeneca
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb 
  • Amgen Inc.
  • Biogen Inc.
  • Celgene Corporation (now part of Bristol Myers Squibb)
  • Illumina, Inc.
  • Novo Nordisk A/S
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Roche Holding AG
  • Genentech, Inc. (a subsidiary of Roche Holding AG)
  • Moderna, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Lonza Group AG
  • Pfizer Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Biotechnology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Biotechnology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Biotechnology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Biotechnology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Biotechnology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Biotechnology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Biotechnology Market size was valued at USD 1055.7 billion in 2021 and is poised to grow from USD 1202.44 billion in 2022 to USD 3879.51 billion by 2030, growing at a CAGR of 13.9% in the forecast period (2023-2030).

Global biotechnology market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'AstraZeneca', 'Gilead Sciences, Inc.', 'Bristol-Myers Squibb ', 'Amgen Inc.', 'Biogen Inc.', 'Celgene Corporation (now part of Bristol Myers Squibb)', 'Illumina, Inc.', 'Novo Nordisk A/S', 'Thermo Fisher Scientific Inc.', 'AbbVie Inc.', 'Regeneron Pharmaceuticals, Inc.', 'Vertex Pharmaceuticals Incorporated', 'Roche Holding AG', 'Genentech, Inc. (a subsidiary of Roche Holding AG)', 'Moderna, Inc.', 'Bio-Rad Laboratories, Inc.', 'Qiagen N.V.', 'Agilent Technologies, Inc.', 'Lonza Group AG', 'Pfizer Inc.'

Increasing prevalence of chronic illnesses is believed Chronic conditions are now more common than ever. With the growth of the middle class and the speeding up of urbanization, people are becoming more sedentary. As a result, there are more cases of genetic abnormalities, diabetes, malaria, HIV, and other diseases like TB and obesity. Additional factors driving market revenue growth include an increase in the prevalence of target diseases and genetic anomalies, ongoing technological advancements in Polymerase Chain Reaction technologies, and increased investments, financing, and grants for scientific research. The biopharmaceutical sector aids in the prevention of chronic diseases. Biopharmaceutical sector is focusing on creating individualized therapies. This will help develop individualized procedural healthcare standards and aid in the treatment of some hereditary genetic diseases.

By merging cutting-edge technology, expanding developments in the life sciences are providing significant advantages for healthcare interventions and productivity. Innovative technique development and company adoption have a beneficial impact on the biotech industry and are expected to drive significant market growth. Medicine is utilizing cutting-edge technologies, such as 3D bioprinting. Heart valves, cartilage, and skin are just a few of the bodily parts that may be developed using 3D bioprinting and living cells. The development of medications, tissues, and organs like the liver and heart utilizing patient body cells has a tremendous potential. The spectrum of uses for human cells and tissues in medical research will be further expanded because accurate models for research and analysis will be made available.

Global biotechnology market is dominated by North America. The presence of major players, extensive R&D efforts, and high healthcare spending are just a few of the factors driving the regional market's expansion. Platforms based on genomics, proteomics, and cell biology are widely used in the area, which is hastening the uptake of life sciences tools. A further factor that is anticipated to have a positive effect on market growth in the area is the rise in the prevalence of chronic diseases and the increasing use of personalized medicine applications for the treatment of serious illnesses.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biotechnology Market

Product ID: SQSG35H2012

$5,300
BUY NOW GET SAMPLE